Evidence map›Paper›PMID 37959677›Full record

ArticleMolecules (Basel, Switzerland)2023

Sesamin: A Promising Therapeutic Agent for Ameliorating Symptoms of Diabetes.

Shu-Ming Huang, Cheng-Hung Chuang, Christine Joyce F Rejano, Lemmuel L Tayo, Cheng-Yang Hsieh, Steven Kuan-Hua Huang, Po-Wei Tsai

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Shu-Ming HuangDepartment of Clinical Nutrition, Nantou Hospital, Ministry of Health and Welfare, Nantou City 545, Taiwan.
Cheng-Hung ChuangDepartment of Nutrition, Hungkuang University, Taichung City 433, Taiwan.
Christine Joyce F RejanoSchool of Chemical, Biological, Materials Engineering and Sciences, Mapúa University, Manila 1002, Philippines.ORCID 0009-0005-1266-1783
Lemmuel L TayoSchool of Chemical, Biological, Materials Engineering and Sciences, Mapúa University, Manila 1002, Philippines.
Cheng-Yang HsiehPh.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei City 110, Taiwan.ORCID 0000-0003-4225-9128
Steven Kuan-Hua HuangDepartment of Medical Science Industries, College of Health Sciences, Chang Jung Christian University, Tainan 711, Taiwan.
Po-Wei TsaiLaboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.ORCID 0000-0002-1981-5360
Kaohsiung Medical University · TWMapúa University · PHTohoku University · JP

Funding

Taiwan's Ministry of Health and Welfare 109 Research Project
6 · The paper itself

Abstract

Diabetes is a chronic metabolic disease characterized by improperly regulating proteins, carbohydrates, and lipids due to insulin deficiency or resistance. The increasing prevalence of diabetes poses a tremendous socioeconomic burden worldwide, resulting in the rise of many studies on Chinese herbal medicines to discover the most effective cure for diabetes. Sesame seeds are among these Chinese herbal medicines that were found to contain various pharmacological activities, including antioxidant and anti-inflammatory properties, lowering cholesterol, improving liver function, blood pressure and sugar lowering, regulating lipid synthesis, and anticancer activities. These medicinal benefits are attributed to sesamin, which is the main lignan found in sesame seeds and oil. In this study, Wistar rat models were induced with type 2 diabetes using streptozotocin (STZ) and nicotinamide, and the effect of sesamin on the changes in body weight, blood sugar level, glycosylated hemoglobin (HbA1c), insulin levels, and the states of the pancreas and liver of the rats were evaluated. The results indicate a reduced blood glucose level, HbA1c, TG, and ALT and AST enzymes after sesamin treatment, while increased insulin level, SOD, CAT, and GPx activities were also observed. These findings prove sesamin's efficacy in ameliorating the symptoms of diabetes through its potent pharmacological activities.

Indexed as

Diabetes Mellitus, Type 2LignansAnimalsDioxolesGlycated HemoglobinInsulinPlant ExtractsRatsRats, WistarDioxolesGlycated HemoglobinInsulinLignansPlant Extractssesamindiabetesinsulin resistancesesaminSesamum indicum L.streptozotocin

Identifiers

PMID37959677
PMCPMC10649669
OpenAlexW4387940139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.